These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. [Testicular germ cell tumors: Histopathological and molecular features]. Tourne M; Radulescu C; Allory Y Bull Cancer; 2019 Apr; 106(4):328-341. PubMed ID: 30905378 [TBL] [Abstract][Full Text] [Related]
64. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours. Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927 [TBL] [Abstract][Full Text] [Related]
65. The epigenome of testicular germ cell tumors. Lind GE; Skotheim RI; Lothe RA APMIS; 2007 Oct; 115(10):1147-60. PubMed ID: 18042148 [TBL] [Abstract][Full Text] [Related]
66. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes. Ferlin A; Ganz F; Pengo M; Selice R; Frigo AC; Foresta C Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291 [TBL] [Abstract][Full Text] [Related]
67. Differential expression of protooncogenes in human germ cell tumors of the testis. Shuin T; Misaki H; Kubota Y; Yao M; Hosaka M Cancer; 1994 Mar; 73(6):1721-7. PubMed ID: 7908857 [TBL] [Abstract][Full Text] [Related]
68. Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors - A comparative study with SOX17. Zhou Y; Rothrock A; Murugan P; Li F; Bu L Exp Mol Pathol; 2022 Jun; 126():104761. PubMed ID: 35390309 [TBL] [Abstract][Full Text] [Related]
69. [Updated genomics of testicular germ cell tumor]. Zhang M; He AB; Cai ZM; Wu S Zhonghua Nan Ke Xue; 2015 Apr; 21(4):363-70. PubMed ID: 26027106 [TBL] [Abstract][Full Text] [Related]
70. Tumor-suppressive function of protein-tyrosine phosphatase non-receptor type 23 in testicular germ cell tumors is lost upon overexpression of miR142-3p microRNA. Tanaka K; Kondo K; Kitajima K; Muraoka M; Nozawa A; Hara T J Biol Chem; 2013 Aug; 288(33):23990-9. PubMed ID: 23843459 [TBL] [Abstract][Full Text] [Related]
71. SOX2 and PRAME in the "reprogramming" of seminoma cells. Orsatti A; Sirolli M; Ambrosi F; Franceschini T; Giunchi F; Franchini E; Grillini M; Massari F; Mollica V; Bianchi FM; Colecchia M; Fiorentino M; Ricci C Pathol Res Pract; 2022 Sep; 237():154044. PubMed ID: 35930824 [TBL] [Abstract][Full Text] [Related]
72. Immunohistochemical detection of p63 in testicular germ cell neoplasia. Emanuel PO; Unger PD; Burstein DE Ann Diagn Pathol; 2006 Oct; 10(5):269-73. PubMed ID: 16979518 [TBL] [Abstract][Full Text] [Related]
73. Molecular signatures identified by integrating gene expression and methylation in non-seminoma and seminoma of testicular germ cell tumours. Mallik S; Qin G; Jia P; Zhao Z Epigenetics; 2021; 16(2):162-176. PubMed ID: 32615059 [TBL] [Abstract][Full Text] [Related]
74. [Molecular Pathogenesis of Testicular Germ Cell Tumors]. Bakardjieva-Mihaylova V; Škvárová Kramarzová K; Slámová M; Büchler T; Boublíková L Klin Onkol; 2017; 30(6):412-419. PubMed ID: 29271211 [TBL] [Abstract][Full Text] [Related]
75. Cripto: Expression, epigenetic regulation and potential diagnostic use in testicular germ cell tumors. Spiller CM; Gillis AJ; Burnet G; Stoop H; Koopman P; Bowles J; Looijenga LH Mol Oncol; 2016 Apr; 10(4):526-37. PubMed ID: 26654129 [TBL] [Abstract][Full Text] [Related]
76. High-throughput microRNAome analysis in human germ cell tumours. Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849 [TBL] [Abstract][Full Text] [Related]
77. The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo. Jostes S; Nettersheim D; Fellermeyer M; Schneider S; Hafezi F; Honecker F; Schumacher V; Geyer M; Kristiansen G; Schorle H J Cell Mol Med; 2017 Jul; 21(7):1300-1314. PubMed ID: 28026145 [TBL] [Abstract][Full Text] [Related]
78. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine. Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464 [TBL] [Abstract][Full Text] [Related]
79. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling. Cools M; Wolffenbuttel KP; Hersmus R; Mendonca BB; Kaprová J; Drop SLS; Stoop H; Gillis AJM; Oosterhuis JW; Costa EMF; Domenice S; Nishi MY; Wunsch L; Quigley CA; T'Sjoen G; Looijenga LHJ Hum Reprod; 2017 Dec; 32(12):2561-2573. PubMed ID: 29121256 [TBL] [Abstract][Full Text] [Related]
80. Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. Biswal BK; Beyrouthy MJ; Hever-Jardine MP; Armstrong D; Tomlinson CR; Christensen BC; Marsit CJ; Spinella MJ PLoS One; 2012; 7(12):e53003. PubMed ID: 23300844 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]